References

BJA (Bureau of Justice Assistance), U.S. Department of Justice. (2013). Residential substance abuse treatment (RSAT) training tool: Medication assisted treatment for offender populations. Washington, DC.

Cicero, T. J., Inciardi, J. A., & Munoz, A. (2005). Trends of abuse in OxyContin and other opioid analgesics in the United States: 2002–2004. The Journal of Pain, 6(10), 662–672.

Davis, J. M., Severtson, S. G., Bucher-Bartelson, B., & Dart, R. X. (2014). Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits.  Pharmacoepidemiology and Drug Safety, 23(1), 18–25.

GAO (Government Accountability Office). (2009). Methadone-associated overdose deaths: Factors contributing to increased deaths and efforts to prevent them. Washington: U.S. Government Accountability Office. Available at http://www.gao.gov/new.items/d09341.pdf

Inciardi, J. A., Surratt, H. L., Cicero, T., Kurtz, S. S., & Parrino, M. W. (2009). The ‘black box’ of prescription drug diversion. Journal of Addictive Diseases, 28(4), 332–347.

Lavonas, E. J. , Severtson, S. G., Matinez, E. M., Bucher-Bartelson, B., Le Lait, M.-C., Green, J. L., … Dart, R. C. (2014). Abuse and diversion of buprenorphine sublingual tablets and film. Journal of Substance Abuse Treatment, 47, 27–34.

Legal Action Center. (2011). Legality of denying access to medication assisted treatment in the criminal justice system. New York, NY.

Leshner, A. I. (2001). Addiction is a brain disease. Issues in Science and Technology, XVII, 3. Dallas, TX.

Magura, S., & Rosenblum, A. (2001). Leaving methadone treatment: Lessons learned, lessons forgotten, lessons ignored. Mount Sinai Journal of Medicine, 68(1), 62–74.

Muhuri, P. K., Gfroerer, J. C., & Davies, C. (2013). Associations of nonmedical pain reliever use and initiation of heroin use in the United States. CBHSQ Data Review. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration.

NADCP (National Association of Drug Court Professionals). (2013). Adult drug court best practice standards, 1. Alexandria, VA.

NIDA. (2012a). Medication-assisted treatment for opioid addiction. Retrieved from http://www.drugabuse.gov/sites/default/files/tib_mat_opioid.pdf

NIDA. (2012b). Is the use of medications like methadone and buprenorphine simply replacing one addiction with another? Principles of drug addiction treatment: A research based guide, third edition. Retrieved from http://www.drugabuse.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition/frequently-asked-questions/use-medications-methadone-buprenorphine

NIDA. (2009). Drug facts: Treatment approaches for drug addiction. Retrieved from

http://www.drugabuse.gov/publications/drugfacts/treatment-approaches-drug-addiction

NIH (National Institutes of Health). (1997). Effective treatment of opiate addiction. 15 NIH Consensus Statement. November 17–19).

ONDCP (Office of National Drug Control Policy). (2014). National drug control strategy. Washington, DC.

Paulozzi, L. J., Budnitz, D. S., & Xi, Y. (2006).  Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiology and Drug Safety, 15(9), 618–627.

Pletcher, M. J., Kertesz, S. G., Kohn, M. A., & Gonzales, R. (2008). Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA 299(1), 70–78.

Reifler, L. M., Droz, D., Bailey, E., Schnoll, S. H., Dart, R. C., & Bucher-Bartelson, B. (2012). Do prescription monitoring programs impact state trends in Opioid abuse/misuse? Pain Medicine, 13, 434–442.

SAMHSA (Substance Abuse and Mental Health Services Administration (2015) Federal Guidelines for Opioid Treatment Programs. Publication No. (SMA) PEP15 – FEDGUIDEOTP.

SAMHSA (Substance Abuse and Mental Health Services Administration. (2013a). Results from the 2012 National Survey on Drug Abuse and Health: Summary of national findings. NSDUH Series H-46, Publication No. (SMA) 13-4795. Center for Behavioral Health and Statistics Quality. U.S. Department of Health and Human Services. Rockville, MD.

SAMHSA (Substance Abuse and Mental Health Services Administration). (2013b). Einstein expert panel: Medication-assisted treatment in the criminal justice system. Rockville, MD. Retrieved from http://www.samhsa.gov/sites/default/files/mat-criminal-justice-panel-2011.pdf

SAMHSA (Substance Abuse and Mental Health Services Administration. (2010). Methadone mortality: A 2010 reassessment. U. S. Department of Health and Human Services. Center for Substance Abuse Treatment. Draft paper.

SAMHSA (Substance Abuse and Mental Health Services Administration. (2007). Methadone mortality: A reassessment. U.S. Department of Health and Human Services. Center for Substance Abuse Treatment. Draft paper.

SAMHSA (Substance Abuse and Mental Health Services Administration. (2005). Medication-assisted treatment for opioid addiction in opioid treatment programs. Pub. No. (SMA) 05-4048. Treatment Improvement Protocol 43. U.S. Department of Health and Human Services. Rockville, MD.

SAMHSA (Substance Abuse and Mental Health Services Administration. (2004). Methadone-associated mortality: Report of a national assessment. U.S. Department of Health and Human Services. Publication No. (SMA). 04-3904.

SAMHSA (Substance Abuse and Mental Health Services Administration. (2003). Medication-assisted treatment for the 21st century: Community education kit. U.S. Department of Health and Human Services. Rockville, MD. Retrieved from http://adaiclearinghouse.org/downloads/Medication-Assisted-Treatment-for-the-21st-Century-Community-Education-Kit-203.pdf

SAMHSA (Substance Abuse and Mental Health Services Administration. (2001). Opioid drugs in maintenance and detoxification treatment of opiate addiction. Final Rule. Federal Register, Vol. 66, No. 11, Rules and Regulations. 21 CFR Part 291, 42 CFR Part 8.

Schneider, M. F., Bailey, J. E., Cicero, T. J., Dart, R. C., Inciardi, J. A., Parrino, M., & Munoz. (2009). Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Pharmacoepidemiology and Drug Safety, 18(9), 778–790.

Soyka, M. (2014). Buprenorphine use and risk of abuse and diversion. Advances in Pharmacoepidemiology and Drug Safety, 3, 1. Retrieved from http://dx.doi.org/10.4172/2167-1052.1000145

U.S. Department of Justice, National Drug Intelligence Center. (2007, November). Methadone diversion, abuse, and misuse: Deaths increasing at alarming rate. Product No. 2007-Q0317-001.

White, W. L., & Torres, L. M. (2010). Recovery-oriented methadone maintenance. Institute for Research, Education and Training in Addiction. Philadelphia, PA.

 

Share This